Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Feb / The Ultimate Vision for Rare Disease
Genetics and epigenetics Omics Precision medicine Screening and monitoring Molecular Pathology

The Ultimate Vision for Rare Disease

Genomics and computational pathology can take rare disease diagnostics to the next level

By Mike Klein 02/28/2022 Quick Read (pre 2022) 1 min read

Share

Let’s talk about what rare disease means. Between 5 and 7 percent of the population is affected by a rare disease (of which there are over 7,000) – and, heartbreakingly, 30 percent of rare disease patients die within the first five years (1). If we can help accelerate diagnosis and end the diagnostic odyssey when a baby is just starting to show symptoms – and when they can still be treated – then they can live a long, healthy life. For example, Wilson’s disease is a copper buildup disease that affects the liver and the brain. It’s irreversible if the patient goes too long without treatment – but, if we can get them diagnosed and treated quickly, they can live a relatively normal life.

How do we end this diagnostic odyssey? Currently, it takes an average of five years to reach a final diagnosis – and that’s often too late for patients. Hospitals that use whole-genome sequencing are changing the landscape of rare diseases. If we can get a genetic test done quickly, we can take life-saving measures that can really make an impact on these babies, their families, and overall patient outcomes.

The ultimate vision is to do newborn screening with next-generation sequencing for every baby that is born. To achieve this, we need to change our outlook on the world of genomics. It can’t cost a thousand dollars to sequence each genome, followed by thousands of dollars’ worth of experts perusing research papers to find evidence for each variant. This is one of many areas where artificial intelligence can help: pre-curating all the answers for all the rare diseases. If you pre-curate the most likely and most actionable rare diseases and then screen all newborns – let’s say for the top 500 – then you can tell clinicians immediately after birth, even before symptoms arise, when a patient will need ongoing monitoring or treatment. I think this is the future of rare disease diagnosis.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Rare Genomics Institute, “Get the Facts on Rare Diseases” (2021). Available at: https://bit.ly/3IWUqZg.

About the Author(s)

Mike Klein

Mike Klein is CEO of Genomenon, Ann Arbor, Michigan, USA.

More Articles by Mike Klein

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.